ArticlePharmaceuticals (Basel, Switzerland)2022

Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1-4.

Aimin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.